Zhou, Wangda
Predictive Performance of Physiologically Based Pharmacokinetic (PBPK) Modeling of Drugs Extensively Metabolized by Major Cytochrome P450s in Children. [electronic resource]
- Clinical pharmacology and therapeutics 07 2018
- 188-200 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1532-6535
Standard No.: 10.1002/cpt.905 doi
Subjects--Topical Terms: Acetates--metabolism Analgesics, Opioid--metabolism Anti-Asthmatic Agents--metabolism Anti-Inflammatory Agents, Non-Steroidal--metabolism Antifungal Agents--metabolism Bronchodilator Agents--metabolism Child Child, Preschool Cyclopropanes Cytochrome P-450 CYP1A2--metabolism Cytochrome P-450 CYP2C19--metabolism Cytochrome P-450 CYP2C8--metabolism Cytochrome P-450 CYP2C9--metabolism Cytochrome P-450 CYP2D6--metabolism Cytochrome P-450 CYP3A--metabolism Cytochrome P-450 Enzyme System--metabolism Diclofenac--metabolism Esomeprazole--metabolism Histamine H1 Antagonists, Non-Sedating--metabolism Humans Infant Infant, Newborn Itraconazole--metabolism Lansoprazole--metabolism Loratadine--analogs & derivatives Models, Biological Ondansetron--metabolism Pharmaceutical Preparations--metabolism Pharmacokinetics Proton Pump Inhibitors--metabolism Quinolines--metabolism Serotonin Antagonists--metabolism Sufentanil--metabolism Sulfides Theophylline--metabolism Tramadol--metabolism